HOME / Research Group

Research Group

Chirality of Drugs and Chiral Recognition

[RG #65] Chirality of Drugs and Chiral Recognition

November 1995 - August 1996

Organizer:

Israel Agranat (The Hebrew University of Jerusalem)

Read More
The notion of chirality has emerged as a major theme in drug design and discovery. Many of the new chiral drugs are being developed as single enantiomers. Chiral recognition is one of the most significant topics of contemporary stereochemical studies and is an essential component of pharmacological events.

 

Read Less
jianxiong ma

Jianxiong Ma

FELLOW
The Hong Kong University of Science and Technology
men

Jonathan Frankel

FELLOW
The Hebrew University of Jerusalem

Jonathan Frankel is a professor in the Department of Russian and Slavic Studies at The Hebrew University of Jerusalem. His research interests are Russian and Jewish history.

men

David Loy

FELLOW
Xavier University
David is a professor in the Department of Ethics, Religion and Society at Xavier University. His research interests are comparative philosophy and religion, and Buddhist social theory.
men

Bernard Green

FELLOW
The Hebrew University of Jerusalem
Bernard is a professor in the School of Pharmacy at The Hebrew University of Jerusalem. His research interests are: biorganic chemistry; catalytic antibodies; host-guest chemistry; clathrate inclusion chemistry; chirality phenomena.
Pioneering Study on Spin-Orbit Torque in Single Molecules

Pioneering Study on Spin-Orbit Torque in Single Molecules

27 May, 2024

 

 

Former IIAS fellow and member of the "Molecular Electronics" research group, Ferdinand Evers (Karlsruhe Institute of Technology), together with María Camarasa-Gómez and Daniel Hernangómez-Pérez, explores a new way to control magnetism at the molecular level in an important new paper just published in the Journal of Physical Chemistry Letters: "Spin-Orbit Torque in Single-Molecule Junctions from ab Initio".

men

Dov Sagie

FELLOW
Weizmann Institute of Science